|
|
Volumn 12, Issue 9, 2013, Pages 654-
|
|
Trial watch: Clinical trial boost for lentiviral gene therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CEREBROSIDE SULFATASE;
LENTIVIRUS VECTOR;
WISKOTT ALDRICH SYNDROME PROTEIN;
DISEASE COURSE;
EX VIVO GENE TRANSFER;
FOLLOW UP;
GENE DOSAGE;
GENE MUTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
METACHROMATIC LEUKODYSTROPHY;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
WISKOTT ALDRICH SYNDROME;
CLINICAL TRIALS, PHASE I AS TOPIC;
CLINICAL TRIALS, PHASE II AS TOPIC;
GENETIC THERAPY;
GENETIC VECTORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LENTIVIRUS;
LEUKODYSTROPHY, METACHROMATIC;
WISKOTT-ALDRICH SYNDROME;
|
|
EID: 84883413517
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4111 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
